Page 74 - 《南京医科大学学报（自然科学版）》2026年第3期

第46卷第3期
·382 · 南 京 医 科 大 学 学 报 2026年3月

作者贡献声明： generation sequencing［J/OL］. J Med Microbiol，2024，73
杨燕负责选题、设计和文章撰写；胡琴琴负责实施研究； （9）［2025-09-01］. DOI：10.1099/jmm.0.001884
刘裔负责数据整理；黄艳负责数据图标制作；张向荣指导和 ［9］ WANG W，LIU R M，YAO C，et al. Reevaluating rifampi⁃
审阅文章。 cin breakpoint concentrations for Mycobacterium tubercu⁃
Author’s Contributions： losis isolates with disputed rpoB mutations and discordant
YANG Yan was responsible for the topic selection，study susceptibility phenotypes［J］. Microbiol Spectr，2022，10
design and manuscript writing；HU Qinqin was responsible for （1）：e0208721
the research conducting；LIU Yi was responsible for data organi⁃ ［10］张海霞，张 觅，腾晓燕，等. GeneXpert 法与涂片抗酸
zation；HUANG Yan was responsible for the chart production； 染色法检测结核分枝杆菌的比较研究［J］. 南京医科大
ZHANG Xiangrong was responsible for guiding and reviewing 学学报（自然科学版），2022，42（1）：129-132
the article. ZHANG H X，ZHANG M，TENG X Y，et al. Comparative
study of GeneXpert method and acid⁃fast staining for de⁃
［参考文献］
tection of Mycobacterium tuberculosis［J］. Journal of Nan⁃
［1］ World Health Organization. Global tuberculosis report jing Medical University（Natural Sciences），2022，42（1）：
2023［R］. Geneva：World Health Organization，2023
129-132
［2］ 卢春容，谭卫国，陆普选，等. 2023年WHO全球结核病 ［11］赵雁林，逄 宇. 结核病实验室检验规程［M］. 北京：人
报告：全球与中国关键数据分析［J］. 新发传染病电子
民卫生出版社，2015
杂志，2023，8（6）：73-78
ZHAO Y L，PANG Y. Laboratory testing procedures for
LU C R，TAN W G，LU P X，et al. 2023 WHO global tu⁃ tuberculosis diagnosis［M］. Beijing：People’s Medical
berculosis report：analysis of key data worldwide and in Publishing House，2015
China［J］. Journal of Emerging Infectious Diseases，2023， ［12］AGUILAR⁃JIMÉNEZ J R，PELISSARI D M，DIAZ⁃QUI⁃

8（6）：73-78 JANO F A. How has the municipal availability of the Gen⁃
［3］ ERNEST J P，STRYDOM N，WANG Q，et al. Develop⁃ eXpert MTB/RIF system affected the detection of drug⁃re⁃
®
ment of new tuberculosis drugs：translation to regimen sistant tuberculosis in Brazil?［J］. Trop Med Int Health，
composition for drug⁃sensitive and multidrug⁃resistant tu⁃ 2024，29（1）：57-62
berculosis［J］. Annu Rev Pharmacol Toxicol，2021，61： ［13］WHITFIELD M G，WARREN R M，MATHYS V，et al.

495-516 The potential use of rifabutin for treatment of patients
［4］ 王丹吉，刘 巧，陆 伟，等. 基因芯片技术对耐多药结 diagnosed with rifampicin ⁃ resistant tuberculosis［J］. J
核病患者治疗的指导价值［J］. 南京医科大学学报（自 Antimicrob Chemother，2018，73（10）：2667-2674
然科学版），2018，38（7）：983-987 ［14］World Health Organization. Technical report on critical
WANG D J，LIU Q，LU W，et al. Guiding value of gene concentrations for drug susceptibility testing of isoniazid
chip technology in the treatment of patients with multidrug⁃ and the rifamycins（rifampicin，rifabutin and rifapen⁃
resistant tuberculosis［J］. Journal of Nanjing Medical tine）［R］.Geneva：World Health Organization，2021
University（Natural Sciences），2018，38（7）：983-987 ［15］World Health Organization. How to choose a molecular
［5］ WANG W L，ZHOU H J，CAI L，et al. Association be⁃ WHO⁃recommended rapid diagnostic test for tuberculosis
tween the rifampicin resistance mutations and rifabutin and drug ⁃ resistant tuberculosis testing［R］. Geneva：
susceptibility in Mycobacterium tuberculosis：a meta⁃analy⁃ World Health Organization，2022
sis［J］. J Glob Antimicrob Resist，2025，40：53-61 ［16］WOODS G L，BROWN⁃ELLIOTT B A，CONVILLE P S，
［6］ HEAD I M，LAZARUS R. Use of Xpert MTB/RIF in a low et al. Susceptibility testing of mycobacteria，nocardiae，
prevalence setting in the Southwest of England［J］. J In⁃ and other aerobic actinomycetes；approved standard⁃sec⁃
fect，2021，82（1）：159-198 ond edition：M24⁃A2［S］. Wayne，PA：Clinical and Labo⁃
［7］ MOREY⁃LEÓN G，MEJÍA⁃PONCE P M，PARDO J C G， ratory Standards Institute，2011
et al. A precision overview of genomic resistance screen⁃ ［17］SHIVEKAR S S，KALIAPERUMAL V，BRAMMACHA⁃
ing in Ecuadorian isolates of Mycobacterium tuberculosis RRY U，et al. Prevalence and factors associated with mul⁃
using web ⁃ based bioinformatics tools［J］. PLoS One， tidrug⁃resistant tuberculosis in South India［J］. Sci Rep，
2023，18（12）：e0294670 2020，10（1）：17552
［8］ QADIR M，KHAN M T，KHAN S A，et al. Unveiling the ［18］QADIR M，FARYAL R，KHAN M T，et al. Phenotype ver⁃
complexity of rifampicin drug susceptibility testing in My⁃ sus genotype discordant rifampicin susceptibility testing
cobacterium tuberculosis：comparative analysis with next⁃ in tuberculosis：implications for a diagnostic accuracy［J］.